CNTA vs GM · $6.15B cap vs P/E 7.5, rev $91.65B
Centessa Pharmaceuticals PLC ADR (CNTA) versus General Motors Company (GM) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
General Motors Company (GM) is a auto manufacturers company listed on US. It is led by Mary Barra.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported GM revenue for 2026-06-30 was $91.65B. Net income was $3.93B. GM currently screens at market cap $51.33B and trailing P/E 7.5.
CNTA currently screens at market cap $6.15B. GM currently screens at market cap $51.33B and trailing P/E 7.5.
Not investment advice. Open the CNTA and GM stock pages for the full models.
Not investment advice.